← Leaderboards
Olaf Kutsch
University Of Alabama At Birmingham
$19,675,358
Attributed
$19,675,358
Total exposure
18
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,675,358 · 18
By mechanism
R01$7,738,297 · 5
P30$4,638,204 · 4
R33$2,702,254 · 2
R61$1,965,027 · 1
R56$1,599,451 · 3
R21$959,625 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Mark Richard Benfield$15,411
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseHiv-1Cell LineInfectionDesignT-LymphocyteViralLaboratoriesLatent InfectionEventResponseVirusFlow CytometryProgramsMolecularDrug CombinationsPhenotypeFundingTranscription FactorInterestSamplingPharmaceutical PreparationsTechnology
Grant awards (44)
Advanced Technology Core (Core H)$258,071
P30 · FY2025 · AI · contact PI
Advanced Technology Core (Core H)$357,297
P30 · FY2024 · AI · contact PI
Loss of Y-chromosome as a driver of HIV-1 latency$424,254
R56 · FY2023 · AI · contact PI
Core H Basic Research Core$214,571
P30 · FY2023 · AI · contact PI
Core H Basic Research Core$582,570
P30 · FY2022 · AI · contact PI
Control of latent/persistent HIV-1 infection in macrophages/microglia: A key role for the phosphatase PPM1A$185,625
R21 · FY2022 · DA · contact PI
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection$689,627
R33 · FY2021 · AI · contact PI
Core H Basic Research Core$315,519
P30 · FY2021 · AI · contact PI
Control of latent/persistent HIV-1 infection in macrophages/microglia: A key role for the phosphatase PPM1A$222,750
R21 · FY2021 · DA · contact PI
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection$689,627
R33 · FY2020 · AI · contact PI
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells$647,889
R01 · FY2020 · AI · contact PI
Core H Basic Research Core$419,882
P30 · FY2020 · AI · contact PI
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection$657,007
R61 · FY2019 · AI · contact PI
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells$650,499
R01 · FY2019 · AI · contact PI
Core H Basic Research Core$343,788
P30 · FY2019 · AI · contact PI
HTS for copper-activated inhibitors against MRSA$680,458
R01 · FY2018 · AI · contact PI
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection$654,010
R61 · FY2018 · AI · contact PI
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells$650,499
R01 · FY2018 · AI · contact PI
Kinomic analysis of host cell factors controlling latent HIV-1 infection$441,000
R33 · FY2018 · AI · contact PI
Flow Cytometry Core$361,464
P30 · FY2018 · AI · contact PI
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells$662,624
R01 · FY2017 · AI · contact PI
Identification of drugs that induce terminal transcriptional silencing of latent HIV-1 infection$654,010
R61 · FY2017 · AI · contact PI
Kinomic analysis of host cell factors controlling latent HIV-1 infection$441,000
R33 · FY2017 · AI · contact PI
Flow Cytometry Core$297,957
P30 · FY2017 · AI · contact PI
Overcoming HIV-1 transcriptional latency in unresponsive CD4 T cells$455,344
R56 · FY2016 · AI · contact PI
Kinomic analysis of host cell factors controlling latent HIV-1 infection$441,000
R33 · FY2016 · AI · contact PI
Flow Cytometry Core$245,483
P30 · FY2016 · AI · contact PI
HTS for Synergistic Activators of Latent HIV-1 Infection$526,579
R01 · FY2015 · AI · contact PI
Kinomic analysis of host cell factors controlling latent HIV-1 infection$330,750
R21 · FY2015 · AI · contact PI
Flow Cytometry Core$206,538
P30 · FY2015 · AI · contact PI
HTS for Synergistic Activators of Latent HIV-1 Infection$526,579
R01 · FY2014 · AI · contact PI
Flow Cytometry Core$265,161
P30 · FY2014 · AI · contact PI
Kinomic analysis of host cell factors controlling latent HIV-1 infection$220,500
R21 · FY2014 · AI · contact PI
HTS for Synergistic Activators of Latent HIV-1 Infection$506,783
R01 · FY2013 · AI · contact PI
Flow Cytometry$201,651
P30 · FY2013 · AI · contact PI
Flow Cytometry$568,252
P30 · FY2012 · AI · contact PI
HTS for Inhibitors of HIV-1 Latency Establishment$719,853
R56 · FY2011 · AI · contact PI
HTS for inhibitors of HIV-1 latency establishement$690,696
R01 · FY2010 · AI · contact PI
HTS for inhibitors of HIV-1 latency establishement$694,163
R01 · FY2009 · AI · contact PI
HTS for inhibitors of HIV-1 latency establishement$533,733
R01 · FY2008 · AI · contact PI
A GFP-based HTS Assay for HIV-1 Reactivating Agents$310,387
R01 · FY2007 · AI · contact PI
A GFP-based HTS Assay for HIV-1 Reactivating Agents$319,657
R01 · FY2006 · AI · contact PI
A GFP-based HTS Assay for HIV-1 Reactivating Agents$337,751
R01 · FY2005 · AI
A GFP Based HTS Assay for HIV-1 Tat Inhibitors (RMI)$72,500
R03 · FY2004 · NS